FDA Adverse Event
Malfunction
Summary report: N
TELIGEN
MDR report key: 3052806
·
Received April 11, 2013
Report
- Report Number
- 2124215-2013-03947
- Event Type
- Malfunction
- Date Received
- April 11, 2013
- Date of Event
- April 20, 2012
- Report Date
- March 5, 2013
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE VENTRICULAR IMPEDANCE MEASUREMENTS INCREASED APPROXIMATELY 150 OHMS. ADDITIONALLY, THERE WAS LOW AMPLITUDE AND NOISE NOTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 155657 | TELIGEN | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | F110 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |